Authors: BODERE FK BARDET S VUILLEZ JP BARDIES M GAUTHEROT E ROUVIER E BARBET J CHATAL JF

Citation: Fk. Bodere et al., PHASE I II TRIAL OF 2-STEP RADIOIMMUNOTHERAPY IN MEDULLARY-THYROID CANCER (MTC) USING BISPECIFIC ANTI-CEA/ANTI-DTPA-IN ANTIBODY AND IODINE-131-LABELED BIVALENT HAPTEN/, The Journal of nuclear medicine, 39(5), 1998, pp. 1084-1084